Cellevate starts using SmiLe’s newly upgraded laboratories equipped for gene therapy applications

Cellevate starts using SmiLe’s newly upgraded laboratories equipped for gene therapy applications

LUND, Sweden – Cellevate AB, an innovative biotech company that develops the next generation of cell culture systems designed to revolutionize biomanufacturing, has started performing the cell culture experiments for the validation of the Cellevat3d™ microcarriers in the modern laboratories provided by SmiLe Incubator, located at Medicon Village in Lund.

“As SmiLe alumni members, we are grateful for the possibility to get access to their newly upgraded laboratories in very close vicinity to our facility. This enables us to accelerate time to results, which plays an important role in building the commercialization of Cellevat3d™ microcarriers to cell and gene therapy applications in 2024”, says Laura Chirica, CEO Cellevate.

Read more in the press release from SmiLe Incubator, October 5, 2022.

Photo: Jenny Leyman

For more information, please contact:

Laura Chirica, PhD

CEO Cellevate

Email: laura.chirica@cellevate.com

 

About Cellevate

Cellevate is a spin out from NanoLund – a world leading nanomaterial academical center. The company founded in 2014, develops and markets products based on a proprietary nanofiber-based platform – the Cellevat3d™ – a game-changing, green and sustainable, deep-tech innovation for the biopharmaceutical industry. This platform allows for an industrial-scale production of microcarriers with unparalleled surface area for cell growth, reproducibility and customization. Cellevat3d™ microcarriers products are designed for laboratory testing of cell lines as well as pilot and large-scale batch production of novel classes of biological therapies, including cell- and gene therapies and vaccines. Cellevat3d™ microcarriers have a commercial launch and sales start planned for 2024.

For more information, please visit www.cellevate.com.

About SmiLe Incubator

SmiLe Incubator is a life science business incubator based in Medicon Village in Lund, Sweden. SmiLe helps entrepreneurs commercialize their ideas. There are currently 30 companies in SmiLe which, together with alumni companies, have attracted more than EUR 664 million in venture capital to date since 2014. SmiLe offers excellent business coaching, a broad international network of contacts and a dynamic community, as well as well-equipped laboratories which is unique of its kind in Sweden. SmiLe is a non-profit organization and receives basic funding from Region Skåne, Lund Municipality, Lund University and Medicon Village. SmiLe´s sponsors are Agilent, Sparbanken Skåne, Awa, Høiberg, Prevas, Setterwalls, Zacco, Magle Chemoswed, NanoTemper Technologies, Phase Holographic Imaging and ChemoMetec. SmiLe’s 20 listed alumni companies have a market capitalization of more than EUR 824 million (Q4 2021). www.smileincubator.life

Cellevate